Are we nearly there yet? Coverage and compliance of mass drug administration for lymphatic filariasis elimination. [PDF]
Lymphatic filariasis has been targeted for elimination by 2020, and a threshold of 65% coverage of mass drug administration (MDA) has been adopted by the Global Programme to Eliminate Lymphatic Filariasis (GPELF).
Alexander, Neal DE
core +1 more source
Characterization Of The Homologs Of A Diagnostically Significant Brugia Malayi Gene (Bm17DIII) In Wuchereria Bancrofti, Loa Loa and Onchocerca Volvulus [RA644.F5 R788 2007 f rb]. [PDF]
Satu ujian pantas yang dikenali sebagai BRUGIArapid (BR) yang mengesan antibodi IgG4 terhadap antigen rekombinan B. malayi (BmR1) adalah sangat berguna dalam pemetaan dan pengawasan kawasan yang endemik bagi filariasis brugia.
Abdul Aziz, Ros Azeana
core +1 more source
Screening mosquito house entry points as a potential method for integrated control of endophagic filariasis, arbovirus and malaria vectors. [PDF]
BACKGROUND\ud \ud Partial mosquito-proofing of houses with screens and ceilings has the potential to reduce indoor densities of malaria mosquitoes. We wish to measure whether it will also reduce indoor densities of vectors of neglected tropical diseases.\
Ngonyani, Hassan +36 more
core +1 more source
Factors associated with the performance and cost-effectiveness of using lymphatic filariasis transmission assessment surveys for monitoring soil-transmitted helminths: a case study in Kenya. [PDF]
Transmission assessment surveys (TAS) for lymphatic filariasis have been proposed as a platform to assess the impact of mass drug administration (MDA) on soil-transmitted helminths (STHs).
Smith, Jennifer L +7 more
core +1 more source
Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision by scaling up, scaling down, and reaching out [PDF]
This report summarizes the 7th meeting of the Global Alliance to Eliminate Lymphatic Filariasis (GAELF), Washington DC, November 18–19, 2012. The theme, “A Future Free of Lymphatic Filariasis: Reaching the Vision by Scaling Up, Scaling Down and Reaching ...
Global Alliance, Eliminate Lymphatic Filariasis +1 more
core +1 more source
Why do individuals comply with mass drug administration for lymphatic filariasis? A case study from Alor District, Indonesia [PDF]
Lymphatic filariasis (LF) is a parasitic disease affecting more than 120 million people; over a billion persons live at risk for infection. Filariasis does not kill, but rather disables; making it an important public health -and socio-economic issue ...
Krentel, Alison
core +1 more source
Assessing the presence of Wuchereria bancrofti in vector and human populations from urban communities in Conakry, Guinea [PDF]
The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 with the goal of interrupting transmission of lymphatic filariasis (LF) through multiple rounds of mass drug administration (MDA).
Bockarie, Moses J. +25 more
core +1 more source
The geographic distribution of loa loa in Africa : results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA) [PDF]
Background: Loiasis is a major obstacle to ivermectin treatment for onchocerciasis control and lymphatic filariasis elimination in central Africa. In communities with a high level of loiasis endemicity, there is a significant risk of severe adverse ...
Noma, Mounkaila +6 more
core +4 more sources
Urban Lymphatic Filariasis in the Metropolis of\ud Dar es Salaam, Tanzania [PDF]
The last decades have seen a considerable increase in urbanization in Sub-Saharan Africa, and it is estimated that over 50% of the population will live in urban areas by 2040.
Simonsen, Paul E +4 more
core
Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia. [PDF]
: BACKGROUND: The World Health Organization (WHO) Global Program to Eliminate Lymphatic Filariasis relies on mass drug administration (MDA) of two drugs annually for 4 to 6 years.
Jacob Maikere +5 more
core +1 more source

